Particularly, these authors have classified prostate cancers according to their mRNA microarray signature profiles indicating stem cell expression patterns (stemness), inactivation of the tumor suppressors PTEN and TP53, TMPRSS2-ERG fusion, and activation of some oncogenic pathways [344]. The gene discussed is TMPRSS2; the disease is prostate carcinoma.